Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 14

1.

Marijuana for Glaucoma: A Recipe for Disaster or Treatment?

Sun X, Xu CS, Chadha N, Chen A, Liu J.

Yale J Biol Med. 2015 Sep 3;88(3):265-9. eCollection 2015 Sep. Review.

2.

Perceived risk of regular cannabis use in the United States from 2002 to 2012: differences by sex, age, and race/ethnicity.

Pacek LR, Mauro PM, Martins SS.

Drug Alcohol Depend. 2015 Apr 1;149:232-44. doi: 10.1016/j.drugalcdep.2015.02.009. Epub 2015 Feb 17.

3.

Pharmacotherapies for cannabis dependence.

Marshall K, Gowing L, Ali R, Le Foll B.

Cochrane Database Syst Rev. 2014;(12):CD008940. doi: 10.1002/14651858.CD008940.pub2. Epub 2014 Dec 17. Review.

4.

Gender differences in cannabis use disorders: results from the National Epidemiologic Survey of Alcohol and Related Conditions.

Khan SS, Secades-Villa R, Okuda M, Wang S, PĂ©rez-Fuentes G, Kerridge BT, Blanco C.

Drug Alcohol Depend. 2013 Jun 1;130(1-3):101-8. doi: 10.1016/j.drugalcdep.2012.10.015. Epub 2012 Nov 22.

5.

Identifying risk factors for marijuana use among veterans affairs patients.

Goldman M, Suh JJ, Lynch KG, Szucs R, Ross J, Xie H, O'Brien CP, Oslin DW.

J Addict Med. 2010 Mar;4(1):47-51. doi: 10.1097/ADM.0b013e3181b18782.

6.

A comparison of psychosocial and cognitive functioning between depressed and non-depressed patients with cannabis dependence.

Secora AM, Eddie D, Wyman BJ, Brooks DJ, Mariani JJ, Levin FR.

J Addict Dis. 2010 Jul;29(3):325-37. doi: 10.1080/10550887.2010.489444.

7.

[Pharmacological and psychosocial interventions for cannabis use disorders].

Budney AJ, Vandrey RG, Stanger C.

Rev Bras Psiquiatr. 2010 May;32 Suppl 1:S46-55. Review. Portuguese.

8.

Screening and brief intervention to reduce marijuana use among youth and young adults in a pediatric emergency department.

Bernstein E, Edwards E, Dorfman D, Heeren T, Bliss C, Bernstein J.

Acad Emerg Med. 2009 Nov;16(11):1174-85. doi: 10.1111/j.1553-2712.2009.00490.x.

9.

Cannabis dependence in the San Francisco Family Study: age of onset of use, DSM-IV symptoms, withdrawal, and heritability.

Ehlers CL, Gizer IR, Vieten C, Gilder DA, Stouffer GM, Lau P, Wilhelmsen KC.

Addict Behav. 2010 Feb;35(2):102-10. doi: 10.1016/j.addbeh.2009.09.009. Epub 2009 Sep 19.

10.

A preliminary trial: double-blind comparison of nefazodone, bupropion-SR, and placebo in the treatment of cannabis dependence.

Carpenter KM, McDowell D, Brooks DJ, Cheng WY, Levin FR.

Am J Addict. 2009 Jan-Feb;18(1):53-64. doi: 10.1080/10550490802408936.

11.

Marijuana neurobiology and treatment.

Elkashef A, Vocci F, Huestis M, Haney M, Budney A, Gruber A, el-Guebaly N.

Subst Abus. 2008;29(3):17-29. doi: 10.1080/08897070802218166. Review.

12.

Cognitive deficits in marijuana users: Effects on motivational enhancement therapy plus cognitive behavioral therapy treatment outcome.

Aharonovich E, Brooks AC, Nunes EV, Hasin DS.

Drug Alcohol Depend. 2008 Jun 1;95(3):279-83. doi: 10.1016/j.drugalcdep.2008.01.009. Epub 2008 Mar 7.

13.

Marijuana dependence and its treatment.

Budney AJ, Roffman R, Stephens RS, Walker D.

Addict Sci Clin Pract. 2007 Dec;4(1):4-16. Review.

14.

Negative consequences associated with dependence in daily cannabis users.

Looby A, Earleywine M.

Subst Abuse Treat Prev Policy. 2007 Jan 10;2:3.

Items per page

Supplemental Content

Write to the Help Desk